Skip to main content
Top
Published in: Osteoporosis International 3/2014

01-03-2014 | Original Article

Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases

Authors: V. Bottai, S. Giannotti, G. Dell’osso, G. De Paola, A. Menconi, F. Falossi, G. Raffaetà, G. Guido

Published in: Osteoporosis International | Issue 3/2014

Login to get access

Abstract

Summary

There is still no clarity on the etiology and epidemiology of atypical femoral fractures. The purpose is to show, after a radiological review, that the incidence of atypical fractures is higher than that reported in the literature when compared to “typical” fractures that occurred in the same anatomical site.

Introduction

At present, it is difficult to define the true incidence of atypical fractures associated with bisphosphonate. Our purpose is to show that the incidence of atypical fractures is higher than that reported in the literature when compared to “typical” fractures that occurred in the same anatomical site.

Methods

The authors analyzed 319 femoral fracture Rxs of patients over 60 who have had access to the PS of Clinical Orthopaedics and Traumatology II of the University of Pisa from January 2011 to February 2013. The atypical fractures have been investigated from clinical point of view, biohumoral exams, densitometry and contralateral femur X-rays, and in one case using SPECT-Tc.

Results

The total number of femoral fractures was 319. The medial femur fractures were 60 (46 females and 14 males), and the lateral ones were 316 (237 females and 79 males). Subtrochanteric and diaphyseal fractures were 40 (29 females and 11 males). Among these cases, two atypical fracture cases were related to female patients, one was 79 years old and the other was 77.

Conclusions

The most recent literature reports that the incidence of atypical fractures is 0.6 %. However, taking into consideration only the fracture locations suitable for the identification of atypical fractures, the percentage rises to 5 %. To date, there is still no clarity on the exact etiology of fractures even if it seems to be related to a bone mineral component alteration.
Literature
1.
go back to reference Gradi MK, Watson JT, Cannada LK (2012) Treatment of femoral fracture nonumion after long-term bisphosphonate. Orthopedics 35(6):e991–995CrossRef Gradi MK, Watson JT, Cannada LK (2012) Treatment of femoral fracture nonumion after long-term bisphosphonate. Orthopedics 35(6):e991–995CrossRef
2.
go back to reference American College of Rheumatology (2001) Reccomendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496–1503CrossRef American College of Rheumatology (2001) Reccomendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496–1503CrossRef
3.
go back to reference Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A et al (2002) Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517–523PubMedCrossRef Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A et al (2002) Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517–523PubMedCrossRef
4.
go back to reference Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V et al (2002) Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508–516PubMedCrossRef Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V et al (2002) Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508–516PubMedCrossRef
5.
go back to reference Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294–1301PubMedCrossRef Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294–1301PubMedCrossRef
6.
go back to reference Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358(12):1304–1306, 20PubMedCrossRef Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358(12):1304–1306, 20PubMedCrossRef
7.
go back to reference Annanuntana A, Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM (2013) Atypical femoral fractures: what do we know about them? J Bone Joint Surg Am 95:e8 (1–13) Annanuntana A, Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM (2013) Atypical femoral fractures: what do we know about them? J Bone Joint Surg Am 95:e8 (1–13)
8.
go back to reference Abrahamsen B, Eiken P, Eastell R (2009) Subtrochanteric and diaphyseal femur fractures in patients trested with alendronate: a register-based national cohort study. J Bone Miner Res 24:1095–1102PubMedCrossRef Abrahamsen B, Eiken P, Eastell R (2009) Subtrochanteric and diaphyseal femur fractures in patients trested with alendronate: a register-based national cohort study. J Bone Miner Res 24:1095–1102PubMedCrossRef
9.
go back to reference Giusti A, Hamdy NAT, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:966–971PubMedCrossRef Giusti A, Hamdy NAT, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:966–971PubMedCrossRef
10.
go back to reference Girgis CM, Seibelet MJ (2011) Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis 3(6):301–314, 011 DecPubMedCentralPubMedCrossRef Girgis CM, Seibelet MJ (2011) Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis 3(6):301–314, 011 DecPubMedCentralPubMedCrossRef
12.
go back to reference Mashiba T et al (2011) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524–531CrossRef Mashiba T et al (2011) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524–531CrossRef
13.
go back to reference Carvalho NNC, Voss LA et al (2011) Atypical femoral fractures during prolongued use of bisphosphonates: short-term responses to strontium ranelate and teriparatide. J Clin Metab. doi:10.1210/jc.2011-0593 Carvalho NNC, Voss LA et al (2011) Atypical femoral fractures during prolongued use of bisphosphonates: short-term responses to strontium ranelate and teriparatide. J Clin Metab. doi:10.​1210/​jc.​2011-0593
14.
go back to reference Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM et al (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27(12):2544–2550PubMedCrossRef Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM et al (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27(12):2544–2550PubMedCrossRef
15.
go back to reference Giannotti S, Bottai V, Dell’Osso G, De Paola G, Ghilardi M, Guido G (2013) Pseudoarthrosis in atypical femoral fracture: case report. Osteoporos Int. doi:10.1007/s00198-013-2397-3 Giannotti S, Bottai V, Dell’Osso G, De Paola G, Ghilardi M, Guido G (2013) Pseudoarthrosis in atypical femoral fracture: case report. Osteoporos Int. doi:10.​1007/​s00198-013-2397-3
16.
go back to reference Giannotti S, Bottai V, Dell’Osso G, De Paola G, Pini E, Guido G (2012) Atrophic femoral nonunion successfully treated with teriparatide. Eur J Orthop Surg Traumatol. doi:10.1007/s00590-012-1143-4 Giannotti S, Bottai V, Dell’Osso G, De Paola G, Pini E, Guido G (2012) Atrophic femoral nonunion successfully treated with teriparatide. Eur J Orthop Surg Traumatol. doi:10.​1007/​s00590-012-1143-4
Metadata
Title
Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases
Authors
V. Bottai
S. Giannotti
G. Dell’osso
G. De Paola
A. Menconi
F. Falossi
G. Raffaetà
G. Guido
Publication date
01-03-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 3/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2546-8

Other articles of this Issue 3/2014

Osteoporosis International 3/2014 Go to the issue